In this project, we aimed to determine the effects of the ERα Y537S mutation on ERα/PR crosstalk and resulting transcriptional activity, and to elucidate how this unique interaction contributes to ET resistance in ERα-positive breast cancer. The gene discussed is PGR; the disease is breast carcinoma.